Cardio Diagnostics Holdings, Inc. (CDIOW) stock
CDIOWNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIO
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $4.94MP/E –Yield –
Cardio Diagnostics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cardio Diagnostics's free cash flow for the twelve months ending Dec 31, 2025 was -$5.91M. For fiscal 2025 it was -$5.91M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.91M | – |
| FY2024 | Dec 31, 2024 | -$5.21M | – |
| FY2023 | Dec 31, 2023 | -$6.25M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.34M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.56M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.36M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.41M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.40M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.25M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.22M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.06M | – |